{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T18:50:22Z","timestamp":1765651822382,"version":"3.48.0"},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1007\/s00774-025-01633-8","type":"journal-article","created":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:12:19Z","timestamp":1758042739000},"page":"726-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment on \u201cProbability of achieving treatments goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis\u201d"],"prefix":"10.1007","volume":"43","author":[{"given":"Caroline","family":"Francis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1085-6928","authenticated-orcid":false,"given":"Koyel","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gujar Anantkumar","family":"Jotiram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,16]]},"reference":[{"key":"1633_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-025-01626-7","author":"J Takada","year":"2025","unstructured":"Takada J, Iba K, Takebayashi T, Hanaka M, Akatsuka T, Teramoto A (2025) Probability of achieving treatment goals with twice-weekly teriparatide followed by bisphosphonate in Japanese postmenopausal osteoporosis. J Bone Miner Metab. https:\/\/doi.org\/10.1007\/s00774-025-01626-7","journal-title":"J Bone Miner Metab"},{"key":"1633_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10546","volume":"5","author":"F Cosman","year":"2021","unstructured":"Cosman F, Libanati C, Deignan C, Yu Z, Wang Z et al (2021) Romosozumab followed by antiresorptive treatment increases the probability of achieving bone mineral density treatment goals. JBMR Plus 5:e10546. https:\/\/doi.org\/10.1002\/jbm4.10546","journal-title":"JBMR Plus"},{"key":"1633_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/jbmr.4433","volume":"37","author":"R Eastell","year":"2022","unstructured":"Eastell R, Vittinghoff E, Lui LY, McCulloch CE, Pavo I et al (2022) Validation of the surrogate threshold effect for change in bone mineral density as a surrogate endpoint for fracture outcomes: the FNIH-ASBMR SABRE project. J Bone Miner Res 37:29\u201335. https:\/\/doi.org\/10.1002\/jbmr.4433","journal-title":"J Bone Miner Res"},{"key":"1633_CR4","doi-asserted-by":"publisher","first-page":"2594149","DOI":"10.1155\/2019\/2594149","volume":"2019","author":"L Shi","year":"2019","unstructured":"Shi L, Min N, Wang F, Xue QY (2019) Bisphosphonates for secondary prevention of osteoporotic fractures: a Bayesian network meta-analysis of randomized controlled trials. Biomed Res Int 2019:2594149. https:\/\/doi.org\/10.1155\/2019\/2594149","journal-title":"Biomed Res Int"},{"key":"1633_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1093\/jbmr\/zjae126","volume":"39","author":"T Vilaca","year":"2024","unstructured":"Vilaca T, Schini M, Lui LY, Ewing SK, Thompson AR et al (2024) The relationship between treatment-related changes in total hip BMD measured after 12, 18, and 24\u00a0mo and fracture risk reduction in osteoporosis clinical trials: the FNIH-ASBMR-SABRE project. J Bone Miner Res 39:1434\u20131442. https:\/\/doi.org\/10.1093\/jbmr\/zjae126","journal-title":"J Bone Miner Res"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01633-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-025-01633-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-025-01633-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T18:48:41Z","timestamp":1765651721000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-025-01633-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["1633"],"URL":"https:\/\/doi.org\/10.1007\/s00774-025-01633-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"type":"print","value":"0914-8779"},{"type":"electronic","value":"1435-5604"}],"subject":[],"published":{"date-parts":[[2025,9,16]]},"assertion":[{"value":"20 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no financial interests relevant to this study. The authors declare no non-financial interests relevant to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable as no patient data were collected or analyzed in this commentary.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Generative AI tools, including Paperpal and ChatGPT-4, were utilized solely for language refinement, grammar enhancement, and stylistic refinement. These tools had no role in the conceptualization, data analysis, interpretation of results, or substantive content development of this manuscript. All intellectual contributions, data analysis, and scientific interpretations remain the sole work of the authors. The final content was critically reviewed and edited to ensure accuracy and originality. The authors take full responsibility for the accuracy, originality, and integrity of the work presented.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Generative AI Use statement"}}]}}